May 30, 2017 / 7:56 AM / 2 months ago

BRIEF-A1M Pharma gets notice of allowance for patent application in Canada

1 Min Read

May 30 (Reuters) - A1M PHARMA AB

* RECEIVED A SO-CALLED "NOTICE OF ALLOWANCE" FOR PATENT APPLICATION ENTITLED "DIAGNOSIS AND TREATMENT OF PREECLAMPSIA" FROM CANADIAN INTELLECTUAL PROPERTY OFFICE (CIPO)

* AFTER IT IS FORMALLY APPROVED, THE PATENT WILL BE VALID TO 2028 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below